Skip to main content

Syndax Pharmaceuticals Inc 10-Q for FY2023 Q2

Syndax Pharmaceuticals Inc (SNDX)

10-Q 2023-08-03 For: 2023-06-30
View Original
Added on April 09, 2026

About this 10-Q

Syndax Pharmaceuticals Inc filed this 10-Q on August 3, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$44.62M
compared with a net loss of $37.57M a year earlier
Diluted EPS
-$0.64
compared with -$0.62 a year earlier